Literature DB >> 25797889

Intrauterine growth retardation in foetuses of women with epilepsy.

Anette Huuse Farmen1, Jacob Grundt2, Torbjörn Tomson3, Karl Otto Nakken4, Jakob Nakling5, Petter Mowinchel6, Morten Lossius4.   

Abstract

PURPOSE: Various factors may affect intrauterine foetal growth, amongst which conditions such as epilepsy and the use of anti-epileptic drugs (AED) may play a role. This study investigated intrauterine growth of foetuses in women with epilepsy, as compared with controls, and explored whether intrauterine growth was affected by prenatal exposure to AED.
METHOD: Data were obtained from prospectively registered data regarding pregnancy and prenatal and perinatal factors in women in Oppland County in Norway. The final analysis included information from 166 mothers with epilepsy and 287 children. The control group consisted of 40,553 pregnancies in women without epilepsy registered in the same database.
RESULTS: There was a significantly higher risk of the ponderal index being below the 10th percentile and infants being small for gestational age (SGA) in the epilepsy group; exposure to AED increased the risk. The frequency of SGA and low ponderal index was highest in Lamotrigine exposed infants. In the AED group, head circumference was significantly smaller among Carbamazepine exposed.
CONCLUSION: Impaired intrauterine growth of foetuses in women with epilepsy was identified. The frequency of SGA and low ponderal index was highest in Lamotrigine exposed infants. The epilepsy group had a higher risk profile for having smaller babies, in being younger at age, lower in body weight and more frequent smokers. However despite these differences, the effects of epilepsy and AED exposure were significant. The ponderal index may be a useful supplement to more established measures assessing intrauterine growth in epilepsy.
Copyright © 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Growth restriction; Ponderal index; Pregnancy in epilepsy; Small for gestational age

Mesh:

Substances:

Year:  2015        PMID: 25797889     DOI: 10.1016/j.seizure.2015.02.026

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  4 in total

1.  Short- and long-term complications of in utero exposure to lamotrigine.

Authors:  Merav Cohen-Israel; Itai Berger; Einat Y Martonovich; Gil Klinger; Bracha Stahl; Nehama Linder
Journal:  Br J Clin Pharmacol       Date:  2017-10-22       Impact factor: 4.335

Review 2.  Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis.

Authors:  Gali Pariente; Tom Leibson; Talya Shulman; Thomasin Adams-Webber; Eran Barzilay; Irena Nulman
Journal:  CNS Drugs       Date:  2017-06       Impact factor: 5.749

3.  Increased rate of acute caesarean sections in women with epilepsy: results from the Oppland Perinatal Database in Norway.

Authors:  A H Farmen; J H Grundt; J O Nakling; P Mowinckel; K O Nakken; M I Lossius
Journal:  Eur J Neurol       Date:  2018-12-10       Impact factor: 6.089

4.  Emilia-Romagna Study on Pregnancy and Exposure to Antiepileptic drugs (ESPEA): a population-based study on prescription patterns, pregnancy outcomes and fetal health.

Authors:  Barbara Mostacci; Francesca Bisulli; Elisabetta Poluzzi; Guido Cocchi; Carlo Piccinni; Alessandra Curti; Giuliana Simonazzi; Gianni Astolfi; Nicola Rizzo; Corrado Zenesini; Roberto D'Alessandro; Paolo Tinuper
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-03-16       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.